PPARA and metabolic dysfunction-associated steatotic liver disease: Several LAB strains, some applied in food fermentation processes, were demonstrated to induce the expression of Ppara and its downstream genes involved in fatty acid catabolism, which is regarded as a promising strategy for the supportive treatment in various metabolic diseases, such as NAFLD or obesity.